377 related articles for article (PubMed ID: 29373514)
1. The Ever-Evolving Concept of the Cancer Stem Cell in Pancreatic Cancer.
Valle S; Martin-Hijano L; Alcalá S; Alonso-Nocelo M; Sainz B
Cancers (Basel); 2018 Jan; 10(2):. PubMed ID: 29373514
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic cancer stem cells: A state or an entity?
Hermann PC; Sainz B
Semin Cancer Biol; 2018 Dec; 53():223-231. PubMed ID: 30130664
[TBL] [Abstract][Full Text] [Related]
3. Targeting autophagy in pancreatic cancer: The cancer stem cell perspective.
Troumpoukis D; Papadimitropoulou A; Charalampous C; Kogionou P; Palamaris K; Sarantis P; Serafimidis I
Front Oncol; 2022; 12():1049436. PubMed ID: 36505808
[TBL] [Abstract][Full Text] [Related]
4. The Anthrax Toxin Receptor 1 (ANTXR1) Is Enriched in Pancreatic Cancer Stem Cells Derived from Primary Tumor Cultures.
Alcalá S; Martinelli P; Hermann PC; Heeschen C; Sainz B
Stem Cells Int; 2019; 2019():1378639. PubMed ID: 31191663
[TBL] [Abstract][Full Text] [Related]
5. EMT and Stemness-Key Players in Pancreatic Cancer Stem Cells.
Rodriguez-Aznar E; Wiesmüller L; Sainz B; Hermann PC
Cancers (Basel); 2019 Aug; 11(8):. PubMed ID: 31398893
[TBL] [Abstract][Full Text] [Related]
6. The ever-changing landscape of pancreatic cancer stem cells.
Sancho P; Alcala S; Usachov V; Hermann PC; Sainz B
Pancreatology; 2016; 16(4):489-96. PubMed ID: 27161173
[TBL] [Abstract][Full Text] [Related]
7. Understanding the molecular mechanisms that regulate pancreatic cancer stem cell formation, stemness and chemoresistance: A brief overview.
Nagaraju GP; Farran B; Luong T; El-Rayes BF
Semin Cancer Biol; 2023 Jan; 88():67-80. PubMed ID: 36535506
[TBL] [Abstract][Full Text] [Related]
8. Induction of Lysosome Membrane Permeabilization as a Therapeutic Strategy to Target Pancreatic Cancer Stem Cells.
Cash TP; Alcalá S; Rico-Ferreira MDR; Hernández-Encinas E; García J; Albarrán MI; Valle S; Muñoz J; Martínez-González S; Blanco-Aparicio C; Pastor J; Serrano M; Sainz B
Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32635473
[TBL] [Abstract][Full Text] [Related]
9. Targeting
Alcalá S; Mayoral-Varo V; Ruiz-Cañas L; López-Gil JC; Heeschen C; Martín-Pérez J; Sainz B
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33050159
[TBL] [Abstract][Full Text] [Related]
10. Targeting Pancreatic Cancer Cell Plasticity: The Latest in Therapeutics.
Smigiel JM; Parameswaran N; Jackson MW
Cancers (Basel); 2018 Jan; 10(1):. PubMed ID: 29320425
[TBL] [Abstract][Full Text] [Related]
11. Nanoparticle Delivery of TWIST Small Interfering RNA and Anticancer Drugs: A Therapeutic Approach for Combating Cancer.
Glackin CA
Enzymes; 2018; 44():83-101. PubMed ID: 30360816
[TBL] [Abstract][Full Text] [Related]
12. The role of autophagy in the cross-talk between epithelial-mesenchymal transitioned tumor cells and cancer stem-like cells.
Marcucci F; Ghezzi P; Rumio C
Mol Cancer; 2017 Jan; 16(1):3. PubMed ID: 28137290
[TBL] [Abstract][Full Text] [Related]
13. Epithelial and Mesenchymal-like Pancreatic Cancer Cells Exhibit Different Stem Cell Phenotypes Associated with Different Metastatic Propensities.
Philipp LM; Yesilyurt UU; Surrow A; Künstner A; Mehdorn AS; Hauser C; Gundlach JP; Will O; Hoffmann P; Stahmer L; Franzenburg S; Knaack H; Schumacher U; Busch H; Sebens S
Cancers (Basel); 2024 Feb; 16(4):. PubMed ID: 38398077
[TBL] [Abstract][Full Text] [Related]
14. Epithelial-Mesenchymal Transition in Pancreatic Cancer: A Review.
Wang S; Huang S; Sun YL
Biomed Res Int; 2017; 2017():2646148. PubMed ID: 29379795
[TBL] [Abstract][Full Text] [Related]
15. ISG15 and ISGylation is required for pancreatic cancer stem cell mitophagy and metabolic plasticity.
Alcalá S; Sancho P; Martinelli P; Navarro D; Pedrero C; Martín-Hijano L; Valle S; Earl J; Rodríguez-Serrano M; Ruiz-Cañas L; Rojas K; Carrato A; García-Bermejo L; Fernández-Moreno MÁ; Hermann PC; Sainz B
Nat Commun; 2020 May; 11(1):2682. PubMed ID: 32472071
[TBL] [Abstract][Full Text] [Related]
16. Emerging targets in pancreatic cancer: epithelial-mesenchymal transition and cancer stem cells.
Castellanos JA; Merchant NB; Nagathihalli NS
Onco Targets Ther; 2013 Sep; 6():1261-7. PubMed ID: 24049451
[TBL] [Abstract][Full Text] [Related]
17. Repurposing Established Compounds to Target Pancreatic Cancer Stem Cells (CSCs).
Renz BW; D'Haese JG; Werner J; Westphalen CB; Ilmer M
Med Sci (Basel); 2017 Jun; 5(2):. PubMed ID: 29099030
[TBL] [Abstract][Full Text] [Related]
18. Role of epithelial-mesenchymal transition in chemoresistance in pancreatic ductal adenocarcinoma.
Hu X; Chen W
World J Clin Cases; 2021 Jul; 9(19):4998-5006. PubMed ID: 34307550
[TBL] [Abstract][Full Text] [Related]
19. Fetal bovine serum enlarges the size of human pancreatic cancer spheres accompanied by an increase in the expression of cancer stem cell markers.
Sasaki N; Toyoda M; Hasegawa F; Fujiwara M; Gomi F; Ishiwata T
Biochem Biophys Res Commun; 2019 Jun; 514(1):112-117. PubMed ID: 31027735
[TBL] [Abstract][Full Text] [Related]
20. Hedgehog Signaling Regulates Epithelial-Mesenchymal Transition in Pancreatic Cancer Stem-Like Cells.
Wang F; Ma L; Zhang Z; Liu X; Gao H; Zhuang Y; Yang P; Kornmann M; Tian X; Yang Y
J Cancer; 2016; 7(4):408-17. PubMed ID: 26918054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
